Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children H Visscher, CJD Ross, SR Rassekh, A Barhdadi, MP Dubé, H Al-Saloos, ... Journal of clinical oncology 30 (13), 1422-1428, 2012 | 440 | 2012 |
More codeine fatalities after tonsillectomy in North American children LE Kelly, M Rieder, J van den Anker, B Malkin, C Ross, MN Neely, ... Pediatrics 129 (5), e1343-e1347, 2012 | 435 | 2012 |
Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case–control study P Madadi, CJD Ross, MR Hayden, BC Carleton, A Gaedigk, JS Leeder, ... Clinical Pharmacology & Therapeutics 85 (1), 31-35, 2009 | 379 | 2009 |
Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy CJD Ross, H Katzov-Eckert, MP Dubé, B Brooks, SR Rassekh, ... Nature genetics 41 (12), 1345-1349, 2009 | 363 | 2009 |
Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia LA Magee, S Miremadi, J Li, C Cheng, MHH Ensom, B Carleton, AM Côté, ... American journal of obstetrics and gynecology 193 (1), 153-163, 2005 | 305 | 2005 |
Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update EJ Phillips, C Sukasem, M Whirl‐Carrillo, DJ Müller, HM Dunnenberger, ... Clinical Pharmacology & Therapeutics 103 (4), 574-581, 2018 | 259 | 2018 |
A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer F Aminkeng, AP Bhavsar, H Visscher, SR Rassekh, Y Li, JW Lee, ... Nature genetics 47 (9), 1079-1084, 2015 | 259 | 2015 |
Sildenafil citrate therapy for severe early‐onset intrauterine growth restriction P Von Dadelszen, S Dwinnell, LA Magee, BC Carleton, A Gruslin, B Lee, ... BJOG: An International Journal of Obstetrics & Gynaecology 118 (5), 624-628, 2011 | 229 | 2011 |
Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin LR Brunham, PJ Lansberg, L Zhang, F Miao, C Carter, GK Hovingh, ... The pharmacogenomics journal 12 (3), 233-237, 2012 | 228 | 2012 |
Recommendations for genetic testing to reduce the incidence of anthracycline‐induced cardiotoxicity F Aminkeng, CJD Ross, SR Rassekh, S Hwang, MJ Rieder, AP Bhavsar, ... British journal of clinical pharmacology 82 (3), 683-695, 2016 | 220 | 2016 |
Recommendations for HLA‐B* 15: 02 and HLA‐A* 31: 01 genetic testing to reduce the risk of carbamazepine‐induced hypersensitivity reactions U Amstutz, NH Shear, MJ Rieder, S Hwang, V Fung, H Nakamura, ... Epilepsia 55 (4), 496-506, 2014 | 207 | 2014 |
Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline‐induced cardiotoxicity in children H Visscher, CJD Ross, SR Rassekh, GSS Sandor, HN Caron, ... Pediatric blood & cancer 60 (8), 1375-1381, 2013 | 203 | 2013 |
Direct health care costs associated with asthma in British Columbia M Sadatsafavi, L Lynd, C Marra, B Carleton, WC Tan, S Sullivan, ... Canadian respiratory journal 17 (2), 74-80, 2010 | 190 | 2010 |
Thiazolidinediones and fractures in men and women CR Dormuth, G Carney, B Carleton, K Bassett, JM Wright Archives of internal medicine 169 (15), 1395-1402, 2009 | 183 | 2009 |
SJS/TEN 2017: building multidisciplinary networks to drive science and translation KD White, R Abe, M Ardern-Jones, T Beachkofsky, C Bouchard, ... The Journal of Allergy and Clinical Immunology: In Practice 6 (1), 38-69, 2018 | 170 | 2018 |
Beta-blocker use and COPD mortality: a systematic review and meta-analysis M Etminan, S Jafari, B Carleton, JM FitzGerald BMC pulmonary medicine 12, 1-6, 2012 | 166 | 2012 |
A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children BR Del Pozzo-Magana, A Lazo-Langner, B Carleton, LI Castro-Pastrana, ... Journal of Population Therapeutics and Clinical Pharmacology 18 (1), 2011 | 159 | 2011 |
Central nervous system depression of neonates breastfed by mothers receiving oxycodone for postpartum analgesia J Lam, L Kelly, C Ciszkowski, MLA Landsmeer, M Nauta, BC Carleton, ... The Journal of pediatrics 160 (1), 33-37. e2, 2012 | 142 | 2012 |
Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin‐Induced Hearing Loss in Children K Pussegoda, CJ Ross, H Visscher, M Yazdanpanah, B Brooks, ... Clinical Pharmacology & Therapeutics 94 (2), 243-251, 2013 | 141 | 2013 |
HLA‐A* 31: 01 and HLA‐B* 15: 02 as genetic markers for carbamazepine hypersensitivity in children U Amstutz, CJD Ross, LI Castro‐Pastrana, MJ Rieder, NH Shear, ... Clinical Pharmacology & Therapeutics 94 (1), 142-149, 2013 | 141 | 2013 |